What is the clinical evidence from this study?

Study design: Other. Population: Atrial fibrillation. Intervention: I(KACh) deficiency (knockout model) vs. Wild-type mice. Primary outcome: Induction of atrial fibrillation in the presence of carbachol.

What does this research mean for the field?

Activation of the I(KACh) channel is crucial for the generation of vagally mediated atrial fibrillation, as evidenced by the inability to induce atrial fibrillation in I(KACh)-deficient knockout mice. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore the role of I(KACh) in atrial fibrillation and the effects of its blockade.

June 24, 2026

Evaluation of the role of IKAChin atrial fibrillation using a mouse knockout model

Key Result

Atrial fibrillation was induced by carbachol in 10 of 14 wild-type mice (71.4%) but could not be induced in I(KACh)-deficient knockout mice.

Key Points

This research aims to explore the role of I(KACh) in atrial fibrillation and the effects of its blockade.
Conducted experiments on adult wild-type and I(KACh)-deficient knockout mice.
Compared electrophysiologic features of KO and WT mice with and without carbachol administration.
Assessed the induction of atrial and ventricular arrhythmias in both mouse types.
Atrial fibrillation was induced in 10 out of 14 WT mice with carbachol, lasting an average of 5.7 minutes.
No atrial fibrillation was observed in KO mice.
KO mice showed shorter sinus node recovery times and greater ventricular effective refractory periods compared to WT mice.

Structured PICO

Does I(KACh) deficiency prevent carbachol-induced atrial fibrillation in a mouse model?

Population

Adult wild-type and I(KACh)-deficient knockout mice studied to assess the role of I(KACh) in atrial fibrillation.

Exposure

I(KACh) gene knockout (deficiency) evaluated in the presence and absence of muscarinic receptor agonist carbachol

Comparator

Wild-type (WT) mice

Outcome

Induction of atrial fibrillationsurrogate

Lack of I(KACh) prevented carbachol-induced atrial fibrillation in mice, suggesting specific I(KACh) blockers might be useful for treating AF without adverse ventricular or AV node effects.

Main Result

Absolute Event Rate: 0% vs 71.4%

Abstract

OBJECTIVES: We sought to study the role of I(KACh) in atrial fibrillation (AF) and the potential electrophysiologic effects of a specific I(KACh) antagonist. BACKGROUND: I(KACh) mediates much of the cardiac responses to vagal stimulation. Vagal stimulation predisposes to AF, but the specific role of I(KACh) in the generation of AF and the electrophysiologic effects of specific I(KACh) blockade have not been studied. METHODS: Adult wild-type (WT) and I(KACh)-deficient knockout (KO) mice were studied in the absence and presence of the muscarinic receptor agonist carbachol. The electrophysiologic features of KO mice were compared with those of WT mice to assess the potential effects of a specific I(KACh) antagonist. RESULTS: Atrial fibrillation lasting for a mean of 5.7+/-11 min was initiated in 10 of 14 WT mice in the presence of carbachol, but not in the absence of carbachol. Atrial arrhythmia could not be induced in KO mice. Ventricular tachyarrhythmia could not be induced in either type of mouse. Sinus node recovery times after carbachol and sinus cycle lengths were shorter and ventricular effective refractory periods were greater in KO mice than in WT mice. There was no significant difference between KO and WT mice in AV node function. CONCLUSIONS: Activation of I(KACh) predisposed to AF and lack of I(KACh) prevented AF. It is likely that I(KACh) plays a crucial role in the generation of AF in mice. Specific I(KACh) blockers might be useful for the treatment of AF without significant adverse effects on the atrioventricular node or the ventricles.

Bookmark